Using medical advances made possible by genetic sequencing to facilitate a new era of medical research
- Facilitate the delivery of personalized, efficient medical treatment
- Enable genetically tailored treatment plans
Imagine receiving a cancer diagnosis, and with it a laboratory report that identifies the biological makeup of your cancer, as well as a drug therapy regimen that is designed specifically to attack that cancer and repair your body. Robust sequencing capabilities are critical to the advancement of personalized medicine, as the treatment of disease shifts to therapies that are specific to an individualís unique genetic makeup.
With instruments that unlock the secrets of our DNA, and products and services that advance the promise of regenerative science, we are helping usher in an era of personalized medicine and putting it within the reach of every researcher in every lab.
- Officially launched the Ion Proton™ Sequencer, greatly improving accessibility and speed in genomic sequencing
- Expanded our molecular diagnostics business, acquiring full spectrum capability to develop and commercialize cancer diagnostics where there is currently great unmet need
- Partnered with Boston Children's Hospital to launch Claritas Genomics, a new company formed to develop next-generation, genetic, and genomics-based diagnostic testing solutions
- Collaborated with Translational Genomics Research Institute (TGen) and US Oncology Research on a whole-genome sequencing study that revealed previously unreported mutations in metastatic triple-negative breast cancer (TNBC)
- Unveiled QuantStudio™ 3D Digital PCR System, designed to detect very rare mutations linked to cancer and other genetically based diseases
Launching Claritas Genomics with Boston's Children's Hospital | Read More
Whole-genome Sequencing Study Reveals Previously Unreported Mutations in TNBC | Read More
New TaqMan® Assays Identify Minute Cancer Cells | Read More
Study Targets Hard-to-Treat Triple Negative Breast Cancer | Read More
DNA Analysis Unlocks Medical Mystery for Beery Twins | Read More
Partnering with TGen to Advance Personalized Medicine | Read More